Work

Feasibility of gadolinium contrast use in transcatheter aortic valve implantation: a non-iodine-based procedure—case report

Year: 2025

Type: article

Abstract: Background: Iodine-based contrast agents can be associated to uncommon side effects, as the generalized bullous fixed drug eruption (gbFDE), that cannot be counteracted by drugs. Case summary: We report a case of TAVI performed with a gadolinium-based contrast agent in a patient that had previously experienced a severe form of gbFDE. The patient was successfully treated by a balloon-expandable prosthesis implanted under the guidance of a total of 30 cc of gadolinium injections, avoiding any side effect. Discussion: Thus, the planning of TAVI procedure with zero iodinated contrast is mandatory in high-risk patients for such complication and it is feasible, safe with a gadolinium-based contrast.

Source: European Heart Journal - Case Reports

DOI: 10.1093/ehjcr/ytaf585

Authors: Omar A Oliva, Jerome Van Rothem

Institution: Clinique Pasteur

Language: English

Topic: Cardiac Valve Diseases and Treatments

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $815